您要查找的是不是：
- The analysis can be performed by examining serum or urinary proteins by immunoelectrophoresis. 可用免疫电泳方法进行血清或尿中蛋白的分析。
- Methods Non-concentrated urinary proteins were analyzed with sodium dodecyl sulfate-agarose gel electrophoresis(SDS-AGE)in 49 patients with proteinuria. 方法应用十二烷基磺酸钠-琼脂糖凝胶进行非浓缩尿蛋白电泳分析49例蛋白尿患者的尿蛋白成分。
- CONCLUSION: FSGS is not an accurate prognostic marker in iMN. Histological scoring of FSGS is inferior to measurement of urinary proteins in predicting renal outcome in iMN. 结论:对于特发性膜性肾病;局灶节段性肾小球硬化不是一个精确的预测指标.;通过局灶节段性肾小球硬化组织学评分来衡量尿蛋白水平对于预测特发性膜性肾病病人肾脏转归是牵强的
- Objective To distinguish the sources of the proteinuria by analyzing the compositions of the urinary protein. 目的分析尿蛋白成分来鉴别蛋白尿来源。
- Results: Fenugreek treatment decreased urinary protein excretion,serum creatinine and blood urea nitrogen in dia... 结果:胡芦巴能减少尿蛋白排泄率,降低血肌酐和尿素氮水平,减轻肾脏病变程度。
- There was no correlation between artery blood pressure and RCBF or urinary protein. 平均动脉压在整个病程中与肾皮质血流无显著相关。
- Conclusion: Elastase is an ideal drug in treating urinary protein in patients... 结论:弹性酶是治疗糖尿病肾病蛋白尿的理想药物。
- Objective: To investigate the effects of elastase on urinary protein in diabetic nephropathy. 目的:探讨弹性酶对糖尿病肾病的治疗作用。
- The relation between expressions of ED_1 and MCP-1 was positieelycorrelated with 24-hour urinary protein and creatinine clear rate. 相关分析显示: MCP-1、 ED_1平均光密度值与 24 小时尿微量白蛋白、血清肌酐清除率具有显著直线正相关, MCP-1 与 ED_1平均光密度值二者间也具有正相关。
- The BG,Bp,BUN,Cr and urinary protein excretion rate of 21 NIDDM patients with proteinuria,who were treated for 2 weeks with captopril,were studied. 观察21例伴有蛋白尿的非胰岛素依赖型糖尿病（NIDDM）患者用卡托普利（Captopril）治疗2周前后的尿蛋白排泄率，血糖、血压、血尿素氮（BUN）、血肌酐（Cr）等的变化。
- The levels of blood lipid,blood viscosity,blood creatinine (Cr),blood urea nitrogen(BUN) and urinary protein were detected before and after treatment. 治疗前后检测血脂、血粘度、血肌酐（Cr）、血尿素氮（BUN）及尿蛋白。
- Urinary protein was significantly reduced in T75 after 2 wk of treatment and was also declined in the other two treatment groups but only after 2 mo. 2周后在T75治疗组尿蛋白显著降低，仅在2月后，其他两个治疗组的尿蛋白降低。
- Results: After treatment, the clinical symptoms, urinary protein and immunity improved;the Prednisonum used was lessened obviously. 结果:治疗后患者临床症状、蛋白尿、免疫功能有明显改善,强的松用量显著减少。
- Results: MMF could decrease urinary protein, improve renal function and hematuria, therapeutic efficacy were significantly (P<0.05). 结果：霉酚酸酯能降低尿蛋白，减轻血尿，改善肾功。
- Urinary podocyte excretion level in IgAN patients is correlated with 24 h urinary protein excretion and specific pathological damages. 足细胞尿排泄的水平与蛋白尿水平呈正相关，与肾脏病理类型也有一定的关系。
- Results: At 8th week, kidney weight/body weight (KW/BW) and 24 hours urinary protein count increased significantly in DN model group, compared with control group (P<0.01, P<0.01). 结果8周时糖尿病肾病组肾重/体重比和24小时尿蛋白定量明显增高;与对照组比较有显著性差异(P<0.;01;P<0
- After administration of losartan for 2 weeks and 12 weeks, 24-hour urinary protein excretion (24 hUPE), Scr and Ccr were measured, and renal morphology was observed. 分别于2周和12周杀鼠,观察体重、肾重、肾重/体重指数、尿蛋白量(24 h)、Scr、Ccr以及肾组织病理改变;
- Before and after therapy the changes in quantitative measurement of 24 hours urinary protein,blood creatinine(Cr),complement C3,C4,and antinuclear antibody(ANA) were detected. 在治疗前后检测 2 4小时尿蛋白定量、血肌酐、C3、C4、抗核抗体 (ANA )的变化。
- Blood examination showed leukocytosis, thrombocytopenia, and positive urinary protein, hematuria, urine inside membrane-like manifestations such as renal dysfunction. 血常规检查可见白细胞增多、血小板下降，并有尿蛋白阳性、血尿、尿内出现膜状物等肾功能损害表现。
- The change of recur degree , urinary protein, serum albumin, cholesterol , T cell subpopulation , croticosteroid before and after treatment were observed. 观察治疗前后复发次数及尿蛋白、血清白蛋白、胆固醇、T细胞亚群、血清皮质醇的变化。
